The global antiarrhythmic drugs market size was valued at around USD 1 billion in 2023 and is estimated to grow at 6% CAGR from 2024 to 2032, drive from increasing prevalence of cardiac arrhythmias.
Anti-arrhythmic drug therapy is a frontline treatment for atrial fibrillation (AF), but its success rates are highly variable. This is due to incomplete understanding of the mechanisms of action of sp
Technological advancements in the North America Amiodarone industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transformin
Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether-à-go-go-Related Gene (hERG), which encodes the α subunit of channels carrying rapid delayed rectifier pot
